Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. VREOF
VREOF logo

VREOF News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VREOF News

Vireo Growth Inc. to Purchase More Senior Secured Convertible Notes from Schwazze

Dec 19 2025Yahoo Finance

Vireo Growth secures $49M agreement to acquire PharmaCann's assets in Colorado

Dec 17 2025SeekingAlpha

Vireo Growth Inc. Scheduled to Announce Q3 2025 Results on November 12, 2025

Oct 31 2025Newsfilter

Weekly Update on the Cannabis and Psychedelic Industries

Oct 19 2025Yahoo Finance

Vireo Growth Inc. Finalizes Agreements to Purchase Remaining Senior Secured Convertible Notes from Schwazze

Oct 02 2025Newsfilter

Vireo Growth Inc. Addresses Recent Market Developments; No Knowledge of Significant Changes

Sep 04 2025Newsfilter

Vireo Growth Inc. and Curio Wellness Announce Manufacturing and Distribution Partnership

Jul 01 2025Newsfilter

Vireo Growth Inc. Announces Closing of Proper Brands Acquisition in Missouri

Jun 05 2025Newsfilter

VREOF Events

11/12 08:09
Vireo Growth announces Q3 EPS of 4 cents, up from 2 cents a year ago.
Reports Q3 revenue $91.7M vs. $25.2M last year. Chief Executive Officer John Mazarakis commented, "Our third quarter results reflect continued progress against our objective to create a portfolio of prolific brands in cannabis. Performance was in line with our expectations and is beginning to demonstrate the impact of our efforts to transform the Company through accretive M&A. As we exit 2025 and begin the new year, we will continue optimizing all areas of our business while remaining opportunistic with respect to further acquisitive growth opportunities."
10/29 07:42
Vireo Growth and Verano Holdings Reach Settlement in Legal Disputes
Vireo Growth (VREOF) and Verano Holdings (VRNOF) announced that they have reached a comprehensive settlement dismissing all outstanding litigation matters between the two Companies that are pending before the Supreme Court of British Columbia, Canada. The terms of the Settlement Agreement were approved by the respective Boards of Directors of both Companies. The value of the settlement to Vireo is approximately $10M consisting of the acquisition of certain real estate assets and $1M in cash. The resolution marks the conclusion of a complex legal chapter and reflects a commitment by both Companies to move forward in a constructive manner. Both Companies reiterated their dedication to delivering long-term value to their shareholders and quality products and services to their customers. In a joint statement, the Companies said, "This settlement allows both Vireo and Verano to focus fully on their respective strategic priorities without the distraction of ongoing litigation between the parties."
10/14 08:50
Vireo Growth Completes Acquisition of Convertible Notes from Schwazze
Vireo Growth (VREOF) closed on a transaction to acquire outstanding senior secured convertible notes of public U.S. multi-state cannabis operator, Medicine Man Technologies (SHWZ). The Company simultaneously announced that it has entered into a Restructuring Support Agreement with Schwazze. The RSA sets forth a plan to restructure the operations and capital structure of Schwazze and its subsidiaries through a series of transactions, including, but not limited to, the sale of certain assets representing a majority of the total assets of Schwazze to a newly-formed entity to be majority-owned by Vireo, and the liquidation and winding down of Schwazze's remaining operations. The value of the Notes acquired was approximately $91,000,000, consisting of principal and interest, as of October 10, 2025. The Notes were acquired for total consideration of approximately $62 million, representing a substantial discount to par value. Vireo issued approximately 114,807,815 subordinate voting shares in consideration for the transaction to the previous holders of the Notes. The Notes mature in December of 2026, carry an interest rate of 13.0 percent, and are currently in default. Vireo will assume all rights and remedies of senior secured debt holders in relation to the Notes. Pursuant to the RSA, the collateral agent under the indenture governing the Notes, acting at the direction of Vireo, will submit a credit bid at an auction contemplated to be held in connection with the Asset Sale. If the credit bid is successful, Vireo and Schwazze will enter into an asset purchase agreement with NewCo pursuant to which the assets subject to the Asset Sale would be transferred to NewCo in consideration for an assumption by NewCo of certain specified liabilities of Schwazze and a discharge of the Notes. Certain parties have also agreed to provide NewCo with up to approximately $62 million in financing, the proceeds of which will be used to refinance certain outstanding Schwazze indebtedness, pay transaction expenses and provide NewCo with working capital. Any remaining assets of Schwazze not purchased in the Asset Sale would be subject to a wind down. Net proceeds from the wind down, to the extent there are any, will be distributed to holders of claims and equity interests in Schwazze in accordance with their relative priority under applicable law. Completion of the transactions contemplated by the RSA are subject to certain conditions, including regulatory approval where applicable.
10/14 08:47
Schwazze finalizes deal to reorganize its balance sheet and asset portfolio.
Medicine Man Technologies, Inc., operating as Schwazze (SHWZ) entered into a Restructuring Support Agreement with an affiliate of Vireo Growth (VREOF), which holds a majority of the Company's outstanding 13% senior secured notes due December 7, 2026, the holders of certain outstanding deferred cash seller notes and certain other parties. The RSA sets forth a plan to restructure the operations and capital structure of the Company and its subsidiaries through a series of transactions, including, but not limited to, the sale of certain assets representing a majority of the total assets of the Company and its subsidiaries to a newly-formed entity to be majority-owned by Vireo, and the liquidation and winding down of the Company's remaining operations. The landmark transactions contemplated by the RSA are expected to result in the continuation of our business as a new, growth-oriented company with less debt, improved liquidity and a streamlined asset portfolio. Pursuant to the RSA, the collateral agent under the indenture governing the Senior Secured Notes, acting at the direction of Vireo, will submit a credit bid at an auction contemplated to be held in connection with the Asset Sale. If the credit bid is successful, the Company will enter into an asset purchase agreement with NewCo pursuant to which, subject to receipt of regulatory approvals and other closing conditions, the assets subject to the Asset Sale would be transferred to NewCo in consideration for an assumption by NewCo of certain specified liabilities of the Company and a discharge of all or a majority of the Senior Secured Notes. Certain parties have also agreed to provide NewCo with up to approximately $62 million in financing, the proceeds of which will be used to refinance the Star Buds seller notes, pay transaction expenses and provide NewCo with working capital. Any remaining assets of the Company not purchased in the Asset Sale would be subject to a wind down, and the remaining liabilities of, and equity interests in, the Company will receive the net proceeds from the wind down proceedings in accordance with their relative priorities under applicable law.

VREOF Monitor News

No data

No data

VREOF Earnings Analysis

No Data

No Data

People Also Watch